v3.26.1
Equity Incentive Plan Grants
6 Months Ended
Jun. 30, 2026
Share-Based Payment Arrangement [Abstract]  
Equity Incentive Plan Grants

Note 8. Equity Incentive Plan Grants

 

The Company’s 2021 Equity Incentive Plan (the “2021 Plan”) was originally approved by the Company’s stockholders on October 1, 2021, and has subsequently been amended, most recently pursuant to Amendment No. 3 approved by stockholders on September 4, 2025, to increase the number of shares authorized for issuance under the 2021 Plan to 8.0 million shares. The purpose of the 2021 Plan is to attract and retain directors, consultants, officers and other key employees of the Company and its subsidiaries and to provide to such persons incentives and rewards for superior performance. The 2021 Plan is administered by the Compensation and Management Resources Committee of the Board and has a term of ten years. The 2021 Plan awards may be in the form of stock options (which may be incentive stock options or nonqualified stock options), stock appreciation rights (“SARs”), restricted shares, RSUs, and other share-based awards. As of June 30, 2026, there were approximately 7.9 million shares remaining available for future issuance.

 

In addition, on March 24, 2023, the Board approved an employee stock purchase plan (“FGF ESPP Plan”) whereby qualifying employees can choose each year to have up to 5% of their annual base earnings withheld to purchase the Company’s common shares in the open market. The Company matches 100% of the employee’s contribution amount after thirty days of employment.

 

 

Stock-based compensation expense for the three months ended June 30, 2026 and June 30, 2025 was approximately $0.1 million and $0.3 million, respectively. Stock-based compensation expense for the six months ended June 30, 2026 and June 30, 2025 was approximately $0.2 million and $0.4 million, respectively. As of June 30, 2026, total unrecognized stock compensation expense of approximately $0.4 million remained, which primarily related to RSUs , and will be recognized through June 2031.

 

Restricted Stock Units

 

The following table summarizes activity for RSUs for the six months ended June 30, 2026:

 

Restricted Stock Units 

Number of

Units

  

Weighted

Average

Grant Date

Fair Value

 
Non-vested units, December 31, 2025      $ 
Granted   72,611    4.82 
Exercised        
Expired        
Forfeited        
Non-vested units, June 30, 2026   72,611   $4.82 

 

In April 2026, the Company granted a total of 72,611 RSUs to the members of its Board pursuant to the Company’s director compensation policy.

 

Stock Options

 

The following table summarizes activity for stock options for the six months ended June 30, 2026:

 

Common Stock Options  Shares  

Weighted

Average

Exercise

Price

  

Weighted

Average

Remaining

Contractual

Term (yrs)

  

Weighted

Average

Grant Date

Fair Value

  

Aggregate

Intrinsic

Value

 
Outstanding, December 31, 2025   3,200   $394.06    4.0   $190.49   $ 
Granted                      
Exercised                      
Expired                      
Forfeited                      
Outstanding, June 30, 2026   3,200   $394.06    3.5   $190.49   $ 
Exercisable, June 30, 2026   2,064   $386.01    2.9   $169.72   $